Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Revenue

Kissei Pharmaceutical had revenue of 23.39B JPY in the quarter ending June 30, 2026, with 5.40% growth. This brings the company's total for the last twelve months to 98.60B, up 10.35% year-over-year. In the fiscal year ending March 31, 2026, Kissei Pharmaceutical had annual revenue of 97.41B with 10.28% growth. That makes Kissei Pharmaceutical the 9,937th largest company in the world by revenue and 1,036th in Japan.

• Revenue (ttm): 98.60B
• Revenue Growth: +10.35%
• P/S Ratio: 1.60
• Revenue / Employee: 55.21M
• Employees: 1,786
• Market Cap: 157.85B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals 77.95B 75.2%
• Information Service 17.23B 16.6%
• Construction and Facility Maintenance 7.38B 7.1%
• Goods Sales 1.14B 1.1%

Fiscal year ended Mar 31, 2026 See the full Kissei Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	97.41B	9.08B	10.28%
Mar 31, 2025	88.33B	12.75B	16.87%
Mar 31, 2024	75.58B	8.09B	11.98%
Mar 31, 2023	67.49B	2.11B	3.23%
Mar 31, 2022	65.38B	-3.66B	-5.31%

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error